"Clinical Trials of Texas, LLC (CTT) conducts paid research studies across more than 50 indications in the San Antonio area. CTT's research expertise is applied to conditions that affect the local community such as Diabetes, Fatty Liver, Depression, Women's Health and Arthritis. CTT has been named a repeat Top Workplace and its Chief Medical Director, Dr. Douglas Denham has won national and local awards for his excellence in clinical trials. In addition to paid research studies, CTT offers a variety of free screenings to the community including Memory Screens, Free Liver Scans, Mental and Behavioral Health and Diabetes. Interested participants for either the paid research studies or the free screenings can apply on the website or call CTT."

During the past decade, Clinical Trials of Texas, Inc. conducted 171 clinical trials. In the 10-year time frame, 171 clinical trials started and 121 clinical trials were completed, i.e. on average, 70.8% percent of trials that started reached the finish line to date. In the past 5 years, 66 clinical trials started and 72 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Trials of Texas, Inc." #1 sponsor was "Pfizer" with 39 trials, followed by "Eli Lilly and Company" with 13 trials sponsored, "Allergan" with 9 trials sponsored, "Novavax" with 8 trials sponsored and "Sunovion" with 8 trials sponsored. Other sponsors include 156 different institutions and companies that sponsored additional 118 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Trials of Texas, Inc." #1 collaborator was "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "Department of Health and Human Services" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Athenex, Inc." with 2 trials as a collaborator and "CoLucid Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Trials of Texas, Inc." are "Diabetes Mellitus, Type 2" (13 trials), "Diabetes Mellitus" (9 trials), "Major Depressive Disorder" (8 trials), "Diabetes Mellitus, Type 1" (7 trials) and "Depressive Disorder, Major" (6 trials). Many other conditions were trialed in "Clinical Trials of Texas, Inc." in a lesser frequency.

Most popular intervention types in "Clinical Trials of Texas, Inc." are "Drug" (166 trials), "Biological" (51 trials), "Other" (27 trials), "Device" (8 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (107 trials), "Dasotraline" (5 trials), "BNT162b2" (4 trials), "Rapastinel" (4 trials) and "Tirzepatide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Trials of Texas, Inc." are 212 trials for "All" genders, 20 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Trials of Texas, Inc.". undefined are not yet recruiting, 15 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 180 completed trials in Clinical Trials of Texas, Inc., 2 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Trials of Texas, Inc., 27 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 12 trials that are defined as “Not Applicable".